Concepedia

Author

Jean-Paul Fermand

Hôpital Saint-Louis

Also Known As

Jean-Paul Fermand

19

Publications

4.7K

Citations

16

H-Index

12

Concepts

All Affiliations

Hôpital Saint-LouisHeidelberg UniversityUniversity of PaviaNational and Kapodistrian University of AthensCedars-Sinai Medical Center
JF

About

Jean-Paul Fermand is an author at Hôpital Saint-Louis specializing in medicine, health sciences, and hematology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

2

2

123

2

Medicine

2

2

123

3

Surgical Oncology

1

1

10

4

Adaptive Radiotherapy

1

1

10

5

Cancer Therapeutics

1

1

10

Jean-Paul Fermand

×

9

Publications

2K

Citations

9

H-Index

YearCitations

Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

Lotfi Benboubker, Meletios Α. Dimopoulos, Angela Dispenzieri,

New England Journal of Medicine

2014

780

Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3

Meletios Α. Dimopoulos, Robert A. Kyle, Jean-Paul Fermand,

Blood

2011

448

Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study

Donna Reece, Ute Hegenbart, Vaishali Sanchorawala,

Blood

2011

170

Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study

Donna Reece, Vaishali Sanchorawala, Ute Hegenbart,

Blood

2009

154

Combined Treatment With Arsenic Trioxide and All-Trans-Retinoic Acid in Patients With Relapsed Acute Promyelocytic Leukemia

Emmanuel Raffoux, Philippe Rousselot, Joël Poupon,

Journal of Clinical Oncology

2003

152

Bortezomib, Melphalan, and Dexamethasone for Light-Chain Amyloidosis

Efstathios Kastritis, Xavier Leleu, Bertrand Arnulf,

Journal of Clinical Oncology

2020

140

Update on Recommendations for Assessing Response from the Third International Workshop on Waldenström's Macroglobulinemia

Eva Kimby, Steven P. Treon, Athanasios K. Anagnostopoulos,

Clinical Lymphoma & Myeloma

2006

113

Long-term follow-up from a phase 1/2 study of single-agent bortezomib in relapsed systemic AL amyloidosis

Donna Reece, Ute Hegenbart, Vaishali Sanchorawala,

Blood

2014

66

Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: Results of a prospective clinical trial with 70 stage IIIB-IV patients

Christophe Fermé, Éric Lepage, Pauline Brice,

International Journal of Radiation Oncology*Biology*Physics

1993

10

Page 1